FDA approves a bionic eye

The U.S. Food and Drug Administration recently approved a bionic eye invention designed for people who have retinitis pigmentosa, a rare, hereditary disease that causes cells in the retina to breakdown over time, eventually causing blindness, according to The Atlantic. The device, made by Sylmar, Calif.-based company Second Sight, is called the Argus II Retinal Prosthesis System, and uses "a video camera attached to a pair of Oakley-esque glasses that communicate with electrodes implanted in the retina."

The device currently is available in Europe, and will go on sale in the U.S. later this year. Mark Humayun, a medical professor at the University of Southern California who helped develop the device called the promise for patients "real," adding "we expect it only to improve over time." Article


Fuel Top Line Growth and Increase Membership

In this webinar, payers can learn how to accelerate the sales pipeline and grow membership across all health insurance market segments using comprehensive sales technologies.